Last reviewed · How we verify
Secondarily generalized seizures
Approved treatments
- Fycompa · Catalyst Pharms
Fycompa works by blocking the AMPA glutamate receptor, which is involved in the transmission of nerve impulses. - Fycompa · Eisai Inc.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Secondarily generalized seizures patent landscape — cliff calendar, originator estates, attackable patents
- Secondarily generalized seizures treatment landscape brief
- Secondarily generalized seizures treatment updates RSS
Frequently asked questions about Secondarily generalized seizures
What drugs treat Secondarily generalized seizures?
Tracked treatments include Fycompa.
What is the treatment for Secondarily generalized seizures?
Standard treatment for Secondarily generalized seizures includes Fycompa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Secondarily generalized seizures patent cliff · Secondarily generalized seizures CI report
- Treatment: Fycompa · Catalyst Pharms
- Treatment: Fycompa · Eisai Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing